OpenArc Corporate Advisory’s GSK GSK Stock Holding History

OpenArc Corporate Advisory’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$510K	Buy	9,728 +175	+2%	+$9.26K	0.01%	477
2026 Q1	$527K	Buy	9,553 +637	+7%	+$34.5K	0.01%	432
2025 Q4	$437K	Buy	+8,916	New	+$416K	0.01%	428

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

OpenArc Corporate Advisory's GSK Position: Q2 2026 in Review

OpenArc Corporate Advisory increased its GSK (GSK) stake by 1.8% in Q2 2026, buying an estimated $9.26K and bringing the position to 9,728 shares worth $510K. The position accounts for 0.01% of the portfolio, ranked #477.

OpenArc Corporate Advisory first reported a position in GSK in Q4 2025 and has held it in 3 quarters since. The position peaked at $527K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

OpenArc Corporate Advisory held 9,728 shares of GSK worth $510K as of Q2 2026.
OpenArc Corporate Advisory bought 175 GSK shares in Q2 2026, an estimated $9.26K.
GSK made up 0.01% of OpenArc Corporate Advisory's portfolio in Q2 2026, its #477 holding.
OpenArc Corporate Advisory first reported a position in GSK in Q4 2025 and has held it in 3 quarters since.
OpenArc Corporate Advisory's GSK position peaked at $527K in Q1 2026.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on OpenArc Corporate Advisory's 13F filing for Q2 2026, filed 5 Aug 2026.